News Archive
Resources Section
Contact
UK Office
Only Medics
Second Floor
7 - 11 Station Road
Reading, Berkshire
RG1 1LG, UK
Tel -
+44(0)1189 522799
Email -
info@onlymedics.com
EU Office
Only Medics
Quantum House
22 - 24 Red Lion Court
Fleet Street, London
EC4A 3EB, UK
Tel -
+44(0)2078 221719
Share &
Connect
Keep connected & join the Only Medics Network here.
Specialist Sectors
-
Indian pharma's outlook stable for 2012, says Fitch
Indian pharma's outlook stable for 2012, says Fitch...
-
AZ's Crestor doing well despite generic Lipitor, Brilinta slow but steady
AZ's Crestor doing well despite generic Lipitor, Brilinta slow but steady...
-
Merck KGaA signs $550 million cancer pact with Threshold
Merck KGaA signs $550 million cancer pact with Threshold...
-
AZ cuts do not put UK life sciences sector at risk - ABPI
AZ cuts do not put UK life sciences sector at risk - ABPI...
-
PM Society unveils new look
The PM Society has unveiled a new updated look for the organisation, including new interest groups to reflect UK pharma's priorities. The revamp was unveiled by chairman Neil Copping and new general m...
-
Succinct to join OPEN Health
Specialist med comms consultancy Succinct Communications is to be acquired by the OPEN Health group. OPEN Health is part of the Chime Communications group, which includes the UK’s largest PR Group, ...
-
GP group mounts full opposition to health reforms
The Royal College of GPs is urging the government to scrap its health reform agenda, dealing another blow to the Health Bill. The College, which represents 34,000 GPs in England, said the overhaul had...
-
Merck & Co enjoys healthy quarter but expects flat sales in 2012
Merck & Co enjoys healthy quarter but expects flat sales in 2012...
-
Roche rounds off year with solid performance
A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results for 2011. The group’s net profit rose to 9.34 billion Swiss francs from CHF8.6...
-
Transforming the pharmaceutical industry through services
Katherine Holland explores how pharma could benefit from adopting a new model and moving to providing overall healthcare. Vision, innovation and new business models are all key themes during the Worl...
-
Victoza sales double as Novo Nordisk profits soar
Victoza sales double as Novo Nordisk profits soar...
-
ACA cut US seniors' 2011 drug spending $2.1B, says govt
ACA cut US seniors' 2011 drug spending $2.1B, says govt...
-
Andrew Morgan joins Republic M!
Republic M! has strengthened its team with the appointment of Andrew Morgan as head of operations. Andrew has leadership expertise gained from previous roles within the NHS, both clinical and manageri...
-
Merck posts strong results for 2011
Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011. The US firm saw sales grow 4% for the year to $48 billion, with half of th...
-
AstraZeneca cuts 7,300 jobs on back of profit drop
AstraZeneca cuts 7,300 jobs on back of profit drop...
-
Device ad-vice: dating vs. commitment: pharma vs. devices
In the first of a new series on medical device marketing Nancy Beesley highlights the key ways device marketing is different from pharma marketing. I started in medical advertising more than 20 years...
-
Working Life: Carlos Gallardo, general manager, Almirall
Biography Carlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an MBA from the Stanford Graduate School of Business and an industrial engineeri...
-
AstraZeneca to cut 7,300 jobs as growth stalls
AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said what countries will be affected. AZ said it would pay out around $2.1 billion for the la...
-
Pfizer recalls oral contraceptive for packaging errors
Pfizer has been forced to recall a large volume of oral contraceptive packs distributed in the US market because a packaging error could leave women at risk of an unwanted pregnancy. The company...
-
Zytiga cost too high, says NICE
NICE is not recommending Janssen’s prostate cancer pill Zytiga because of its high cost. Zytiga (abiraterone) is not recommended, in combination with steroids prednisone or prednisolone, as a second...
News
- Feb 02, 2012 Indian pharma's outlook stable for 2012, says Fitch
- Feb 06, 2012 AZ's Crestor doing well despite generic Lipitor, Brilinta slow but steady
- Feb 03, 2012 Merck KGaA signs $550 million cancer pact with Threshold
- Feb 03, 2012 AZ cuts do not put UK life sciences sector at risk - ABPI
- Feb 03, 2012 PM Society unveils new look
Testimonials
- Right from the very start, I have been p...
- Exceptional service demands recognition....
- Thank you for all your help and support ...
- I want to thank you for your help and gu...
- Thank you for all your help and support ...
- Thanks so much for helping me to find a ...
- As of today I have been in-post for 3 mo...
- Thanks so much for your help and negotia...
- We had been trying to recruit for two me...
- I just wanted to put in writing my grati...